DE69819080D1 - Intravaginale Arzneimittelabgabevorrichtung - Google Patents

Intravaginale Arzneimittelabgabevorrichtung

Info

Publication number
DE69819080D1
DE69819080D1 DE69819080T DE69819080T DE69819080D1 DE 69819080 D1 DE69819080 D1 DE 69819080D1 DE 69819080 T DE69819080 T DE 69819080T DE 69819080 T DE69819080 T DE 69819080T DE 69819080 D1 DE69819080 D1 DE 69819080D1
Authority
DE
Germany
Prior art keywords
active agent
drug delivery
intravaginal
delivery device
intravaginal drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69819080T
Other languages
English (en)
Other versions
DE69819080T2 (de
DE69819080T3 (de
Inventor
Shohre Nabahi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26311785&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69819080(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9713360.7A external-priority patent/GB9713360D0/en
Priority claimed from GBGB9724777.9A external-priority patent/GB9724777D0/en
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE69819080D1 publication Critical patent/DE69819080D1/de
Publication of DE69819080T2 publication Critical patent/DE69819080T2/de
Application granted granted Critical
Publication of DE69819080T3 publication Critical patent/DE69819080T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
DE69819080T 1997-06-24 1998-06-23 Intravaginale Arzneimittelabgabevorrichtung Expired - Lifetime DE69819080T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9713360.7A GB9713360D0 (en) 1997-06-24 1997-06-24 Intravaginal drug delivery device
GB9713360 1997-06-24
GB9724777 1997-11-24
GBGB9724777.9A GB9724777D0 (en) 1997-11-24 1997-11-24 Intravaginal drug delivery device

Publications (3)

Publication Number Publication Date
DE69819080D1 true DE69819080D1 (de) 2003-11-27
DE69819080T2 DE69819080T2 (de) 2004-06-24
DE69819080T3 DE69819080T3 (de) 2011-01-13

Family

ID=26311785

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69819080T Expired - Lifetime DE69819080T3 (de) 1997-06-24 1998-06-23 Intravaginale Arzneimittelabgabevorrichtung

Country Status (8)

Country Link
US (2) US6039968A (de)
EP (1) EP0887074B2 (de)
JP (1) JP4054114B2 (de)
AT (1) ATE252370T1 (de)
DE (1) DE69819080T3 (de)
DK (1) DK0887074T4 (de)
ES (1) ES2206865T5 (de)
PT (1) PT887074E (de)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
GB0009914D0 (en) 2000-04-20 2000-06-07 Metris Therapeutics Limited Device
EP1372605A2 (de) * 2001-03-27 2004-01-02 Galen (Chemicals) Limited Vorrichtungen zur intravaginalen verabreichung von antimikrobiellen mitteln
JP2005501096A (ja) 2001-08-17 2005-01-13 ユニヴァーシティ オブ ピッツバーグ 肥満、代謝症候群、糖尿病、血管障害及び腎臓疾患を治療又は予防するエストラジオールメタボライトの投与
US6943267B1 (en) 2001-08-24 2005-09-13 Utah State University Thiophosphonate inhibitors of phosphatase enzymes and metallophosphatases
RU2302883C2 (ru) * 2001-08-31 2007-07-20 Шеринг Ой Система доставки лекарств
US20080279936A1 (en) * 2001-10-10 2008-11-13 The University Of Pittsburgh Estradiol metabolites for reduction of endothelin production
US7005138B2 (en) * 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
JP3684356B2 (ja) 2002-03-05 2005-08-17 株式会社カイジョー 洗浄物の乾燥装置及び乾燥方法
US9993424B2 (en) 2002-03-27 2018-06-12 Allergan Pharmaceuticals International Limited Intravaginal matrix drug delivery devices
TW200306846A (en) * 2002-04-03 2003-12-01 Wyeth Corp Hormone replacement therapy
US20130150810A1 (en) * 2002-04-30 2013-06-13 The Population Council, Inc. Intravaginal ring for the delivery of unique combinations of antimicrobial compositions
WO2004012664A2 (en) * 2002-08-02 2004-02-12 University Of Pittsburgh Administration of estradiol metabolites for inhibition of drug-induced nephrotoxicity
GB0222522D0 (en) * 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US20060194775A1 (en) * 2003-02-20 2006-08-31 University Of Pittsburgh Estradiol metabolites for the treatment of pulmonary hypertension
BRPI0407667A (pt) * 2003-02-20 2006-03-01 Univ Pittsburgh metabólitos de estradiol para o tratamento de hipertensão pulmonar
US7833545B2 (en) * 2003-04-29 2010-11-16 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
CN101014349A (zh) * 2003-06-20 2007-08-08 病毒基因混和公司 抗病毒组合物及其使用方法
US8399013B2 (en) 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
US8404272B2 (en) * 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
EP1646363B1 (de) * 2003-07-10 2013-10-16 Warner Chilcott (Ireland) Limited Intravaginale arzneimittelabgabevorrichtungen
PL1629844T5 (pl) * 2004-07-13 2012-10-31 Bayer Schering Pharma Oy Długoterminowy system dostarczania leku z kontrolowanym początkowym wyrzutem
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
EP1853272A1 (de) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür
WO2006084083A2 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
US7744556B2 (en) * 2005-03-25 2010-06-29 Kimberly-Clark Worldwide, Inc. Delivery tube assembly for an applicator
US7993667B2 (en) 2005-03-25 2011-08-09 Kimberly-Clark Worldwide, Inc. Methods of manufacturing a medicated tampon assembly
US7919453B2 (en) * 2005-03-25 2011-04-05 Kimberly-Clark Worldwide, Inc. Dosage cap assembly for an applicator
US7527614B2 (en) * 2005-03-25 2009-05-05 Kimberly-Clark Worldwide, Inc. Protective tube for a medicated tampon
US9295289B2 (en) * 2005-04-01 2016-03-29 Leslie Jane James Waist-fastening, hip-encompassing apparel with at least one concealed storage compartment
US7708726B2 (en) * 2005-04-28 2010-05-04 Kimberly-Clark Worldwide, Inc. Dosage form cap for an applicator
DK1933810T3 (da) 2005-08-11 2013-01-28 Childrens Medical Center Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
US20070141118A1 (en) * 2005-12-15 2007-06-21 Damico Joyce A Layered dosage form for a medicated tampon assembly
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
BRPI0713203A2 (pt) * 2006-07-12 2012-04-03 Controlled Therapeutics Scotland Ltda inserto, métodos, embalagem, dispositivo recuperável e dispositivo inserìvel
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
EP2062568A1 (de) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy System zur vaginalen Freisetzung
BRPI0820800B8 (pt) 2007-12-11 2021-06-22 Massachusetts Inst Technology dispositivo médico implantável para liberação controlada de droga
SI2249757T1 (sl) * 2008-02-04 2017-10-30 Ferring B.V. Monolitni intravaginalni obroč, ki vsebuje progesteron ter postopki za njegovo izdelavo in uporabo
US9034365B2 (en) 2008-05-20 2015-05-19 Poly-Med, Inc. Biostable, multipurpose, microbicidal intravaginal devices
CN102176931B (zh) 2008-08-09 2015-03-04 麻省理工学院 治疗男性泌尿生殖组织和外周组织的可植入药物递送设备和方法
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
AU2009294545B2 (en) 2008-09-17 2014-07-10 Bayer Oy An inserter
US8419793B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
US8420153B2 (en) * 2008-09-19 2013-04-16 Mentor Worldwide Llc Coating with antimicrobial agents
EA023156B1 (ru) 2009-06-26 2016-04-29 ТАРИС Биомедикал ЛЛК Устройство для доставки лекарств
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
JP2014503554A (ja) 2011-01-10 2014-02-13 タリス バイオメディカル，インコーポレイテッド 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン
CA2825399A1 (en) 2011-02-04 2012-08-09 Taris Biomedical, Inc. Implantable device for controlled release of low solubility drug
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
SG11201507294WA (en) 2013-03-15 2015-10-29 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
KR102385603B1 (ko) 2013-08-19 2022-04-11 타리스 바이오메디컬 엘엘씨 다중 유닛 약물 전달 장치 및 방법
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
WO2016172704A1 (en) 2015-04-23 2016-10-27 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4300561A (en) * 1979-10-22 1981-11-17 Kimberly-Clark Corporation Easily removable tampon
DE3040978A1 (de) † 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
US4624848A (en) * 1984-05-10 1986-11-25 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
IL116433A (en) * 1994-12-19 2002-02-10 Galen Chemicals Ltd INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
US5816248A (en) * 1996-03-29 1998-10-06 Iotek, Inc. Channeled vaginal insert and method for treating urogenital disorders
TW358031B (en) † 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device

Also Published As

Publication number Publication date
EP0887074A2 (de) 1998-12-30
US6039968A (en) 2000-03-21
EP0887074B2 (de) 2010-08-04
DE69819080T2 (de) 2004-06-24
PT887074E (pt) 2004-03-31
DK0887074T4 (da) 2010-11-15
EP0887074A3 (de) 1999-01-07
US6103256A (en) 2000-08-15
ATE252370T1 (de) 2003-11-15
ES2206865T3 (es) 2004-05-16
EP0887074B1 (de) 2003-10-22
JPH119699A (ja) 1999-01-19
DK0887074T3 (da) 2004-02-23
ES2206865T5 (es) 2010-12-30
DE69819080T3 (de) 2011-01-13
JP4054114B2 (ja) 2008-02-27

Similar Documents

Publication Publication Date Title
DK0887074T4 (da) Intravaginalt lægemiddelindgivelsessystem
NZ508470A (en) Matrices formed of polymer and hydrophobic compounds for use in sustained release drug delivery
SE7714066L (sv) Tillforselenhet for biologiskt aktiva emnen
AU4989997A (en) Soluble form osmotic dose delivery system
CA2396152A1 (en) Osmotic device within an osmotic device
DE60005819D1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
FI932789A0 (fi) Emättimensisäinen antosysteemi
ES2171186T3 (es) Composiciones liquidas de difusion.
BR9609696A (pt) Administração oral unidades separadas
AR039130A2 (es) Metodo de administracion de un agente farmaceuticamente activo a un ojo humano
DK0759747T3 (da) Transdermal indretning til administration gennem de-epitheliseret hud
BR0210631A (pt) Composição farmacêutica de liberação prolongada
ATE103819T1 (de) Pharmazeutische praeparate.
ZA927273B (en) Veterinary transdermal active agent delivery device.
PT770384E (pt) Composicoes farmaceuticas solidas anidras para utilizacao vaginal
AR008025A1 (es) Combinación farmacéutica de una tiazolidindiona y un secretagogo de insulina
DK0669826T3 (da) (-)-Metrifonatholdigt lægemiddel

Legal Events

Date Code Title Description
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8366 Restricted maintained after opposition proceedings
8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE ISENBRUCK BOESL HOERSCHLER LLP, 816